KLI

검색

Ulsan Univ. Repository

Browsing by 키워드 : Monoclonal antibodies

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 15건 중 1-15 번을 표시중입니다.

1 Article A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study 2023
2 Article Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial Robin Kate Kelley ; Lorenza Rimassa ; Ann-Lii Cheng ; et al 2022
3 Article Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials Dhananjay Yadav ; Minseok Kwak ; Pallavi Singh Chauhan ; et al 2022
4 Article Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients Evaluating anti-thymocyte globulin induction doses for better allograft and patient survival in Asian kidney transplant recipients 2023
5 Article Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer Peter Schmid ; Javier Cortes ; Rebecca Dent ; et al 2022
6 Article Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial 2023
7 Article Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma Andrew X Zhu ; Alexander R Abbas ; Marina Ruiz de Galarreta ; et al 2022
8 Article Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial Yoon-Koo Kang ; Li-Tzong Chen ; Min-Hee Ryu ; et al 2022
9 Article Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer. Carlos H Barrios ; Shigehira Saji ; Nadia Harbeck ; et al 2022
10 Article Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial 2023
11 Article Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Thomas Powles ; Piotr Tomczak ; Se Hoon Park ; et al 2022
12 Article Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C 2023
13 Article Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Shanu Modi ; William Jacot ; Toshinari Yamashita ; et al 2022
14 Article Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer J. Cortés ; S.-B. Kim ; W.-P. Chung ; et al 2022
15 Article Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial 2023

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.